• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿患者进行自我治疗的障碍。

Barriers to self-administered therapy for hereditary angioedema.

机构信息

Department of Medicine, Penn State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.

出版信息

Allergy Asthma Proc. 2014 May-Jun;35(3):250-4. doi: 10.2500/aap.2014.35.3753.

DOI:10.2500/aap.2014.35.3753
PMID:24801468
Abstract

Presently, the movement of care for hereditary angioedema (HAE) is out of the clinic, emergency department, and hospitals and into the home. Much of the transition relies on specialized nurses who teach patients self-administration skills. Our goal was to assess nurses to uncover barriers that they have encountered in an effort to improve self-therapy education and patient care. A survey of 21 questions was sent to 38 HAE home care nurses throughout the United States. Results were collected anonymously and data were analyzed. Nurses feel that there is an increased need for teaching patients self-therapy skills. The majority are very comfortable teaching self-administration and troubleshooting-associated problems. Perceived difficulties in providing adequate teaching include distance to patient's home and logistics of coordinating, scheduling, and obtaining supplies. Teaching is preferred when done at home by a visiting nurse with a care partner available and multiple training sessions are needed. Very few patients refused self-administration after initially being taught; reasons cited for refusal include fear of injection or infection, lack of skills, interference of daily activities, and financial restraints. As for nurses, they were most worried about safety, lack of skill retention, and inappropriate use of the drug. Self- administration of HAE treatment is increasingly more accessible and should be offered to patients as a safe and practical option. The barriers to self-administration revealed in this study include distance to the patient's home, coordinating care, obtaining medications/equipment, and scheduling training sessions. Moving to self- or home treatment through nursing instruction will improve patient's independence and quality of life, lead to earlier therapy, and reduce costs associated with care.

摘要

目前,遗传性血管性水肿(HAE)的护理工作已经从诊所、急诊室和医院转移到了患者家中。这一转变在很大程度上依赖于专门的护士,他们负责教授患者自我管理技能。我们的目标是评估护士在自我治疗教育和患者护理方面所遇到的障碍,以寻求改进。我们向全美 38 名 HAE 家庭护理护士发送了一份包含 21 个问题的调查。结果是匿名收集的,并进行了数据分析。护士们认为,患者自我治疗技能的教学需求有所增加。大多数护士非常愿意教授自我给药和解决相关问题。在提供足够的教学方面,护士们认为存在一些困难,包括与患者家庭的距离、协调、安排和获得供应品的后勤问题。他们更喜欢由家庭访问护士来进行教学,并且需要有护理伙伴在场和多次培训课程。很少有患者在最初接受教学后拒绝自我给药;拒绝的原因包括害怕注射或感染、缺乏技能、日常活动干扰以及经济限制。至于护士,他们最担心的是安全问题、技能保留问题和药物的不当使用。HAE 治疗的自我管理越来越容易获得,应作为一种安全实用的选择提供给患者。这项研究揭示了自我管理所面临的障碍,包括与患者家庭的距离、协调护理、获得药物/设备以及安排培训课程。通过护理指导实现自我或家庭治疗将提高患者的独立性和生活质量,更早地开始治疗,并降低与护理相关的成本。

相似文献

1
Barriers to self-administered therapy for hereditary angioedema.遗传性血管性水肿患者进行自我治疗的障碍。
Allergy Asthma Proc. 2014 May-Jun;35(3):250-4. doi: 10.2500/aap.2014.35.3753.
2
Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.遗传性血管性水肿发作的急诊科管理:患者视角
J Allergy Clin Immunol Pract. 2017 Jan-Feb;5(1):128-134.e4. doi: 10.1016/j.jaip.2016.06.029. Epub 2016 Sep 21.
3
Patients perception of self-administrated medication in the treatment of hereditary angioedema.患者对遗传性血管性水肿治疗中自我给药药物的认知。
Ann Allergy Asthma Immunol. 2015 Aug;115(2):120-5. doi: 10.1016/j.anai.2015.06.006. Epub 2015 Jun 26.
4
Facilitating home-based treatment of hereditary angioedema.促进遗传性血管性水肿的居家治疗。
Allergy Asthma Proc. 2015 Mar-Apr;36(2):92-9. doi: 10.2500/aap.2015.36.3820. Epub 2014 Dec 30.
5
Current medical management of hereditary angioedema: follow-up survey of US physicians.遗传性血管性水肿的当前医学管理:美国医生的随访调查
J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):220-7. doi: 10.1016/j.jaip.2014.08.017. Epub 2014 Nov 18.
6
Feasibility of home infusion and self-administration of nanofiltered C1 esterase inhibitor for routine prophylaxis in patients with hereditary angioedema and characterization of a training and support program.遗传性血管性水肿患者使用纳米过滤C1酯酶抑制剂进行家庭输注和自我给药用于常规预防的可行性以及一项培训与支持计划的特点
J Infus Nurs. 2014 Jan-Feb;37(1):29-34. doi: 10.1097/NAN.0000000000000018.
7
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema.血浆源性C1抑制剂的家庭治疗:改善遗传性血管性水肿临床结局和成本的策略。
Int Arch Allergy Immunol. 2015;166(4):259-66. doi: 10.1159/000381341. Epub 2015 Apr 28.
8
Assessment on hereditary angioedema burden of illness in Brazil: A patient perspective.巴西遗传性血管性水肿疾病负担评估:患者视角。
Allergy Asthma Proc. 2019 May 1;40(3):193-197. doi: 10.2500/aap.2019.40.4207.
9
On-demand therapy for hereditary angioedema.按需治疗遗传性血管性水肿。
Immunol Allergy Clin North Am. 2013 Nov;33(4):487-94. doi: 10.1016/j.iac.2013.07.004. Epub 2013 Aug 24.
10
Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006-2007.美国 2006-2007 年遗传性血管性水肿急诊就诊的描述性流行病学。
Allergy Asthma Proc. 2011 Sep-Oct;32(5):390-4. doi: 10.2500/aap.2011.32.3478.

引用本文的文献

1
Impact of hereditary angioedema attacks on health-related quality of life and work productivity.遗传性血管性水肿发作对健康相关生活质量和工作生产力的影响。
World Allergy Organ J. 2025 Jul 28;18(8):101083. doi: 10.1016/j.waojou.2025.101083. eCollection 2025 Aug.
2
Epidemiology and treatment of children with hereditary angioedema in Germany: A retrospective database study.德国遗传性血管性水肿患儿的流行病学与治疗:一项回顾性数据库研究。
Clin Transl Allergy. 2023 Nov;13(11):e12313. doi: 10.1002/clt2.12313.
3
Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat.
遗传性血管性水肿发作按需治疗的患者报告结局指标评估及塞贝司他的3期试验KONFIDENT设计
Clin Transl Allergy. 2023 Sep;13(9):e12288. doi: 10.1002/clt2.12288.
4
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.国际血管性水肿学会(WAO)/欧洲变态反应和临床免疫学会(EAACI)遗传性血管性水肿管理指南——2021年修订与更新
World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar.
5
Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France.Lanadelumab用于遗传性血管性水肿的长期预防:法国临时使用授权
Allergy Asthma Clin Immunol. 2022 Apr 1;18(1):30. doi: 10.1186/s13223-022-00664-4.
6
Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study.贝罗他司他治疗遗传性血管性水肿的长期安全性和有效性:开放标签APeX-S研究。
Clin Transl Allergy. 2021 Jun;11(4):e12035. doi: 10.1002/clt2.12035.
7
Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses.利用 HELP 和 CHANGE 研究中的数据进行拉那芦单抗与静脉注射 C1-INH 的间接比较:贝叶斯和频率分析。
Drugs R D. 2021 Mar;21(1):113-121. doi: 10.1007/s40268-021-00337-4. Epub 2021 Mar 1.
8
Hereditary angioedema patients would prefer newer-generation oral prophylaxis.遗传性血管性水肿患者更倾向于新一代的口服预防药物。
J Drug Assess. 2021 Jan 6;10(1):51-56. doi: 10.1080/21556660.2020.1863699.
9
Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.安全性、有效性及对遗传性血管性水肿患者生活质量影响的自我给药血浆源性纳米过滤 C1 抑制剂(Berinert®):SABHA 研究。
Orphanet J Rare Dis. 2018 Apr 10;13(1):51. doi: 10.1186/s13023-018-0797-3.
10
High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study.C1抑制剂缺乏所致血管性水肿患者的高发作频率是转向家庭治疗的主要决定因素:一项真实世界观察性研究
Orphanet J Rare Dis. 2016 Sep 29;11(1):133. doi: 10.1186/s13023-016-0518-8.